VA Study Shows That Pharmacogenomic Testing Improves Outcomes With Depression Treatments
By predicting how medications would be metabolized, clinicians were able to avoid medicines that had a high likelihood of causing negative side effects.
Pharmacogenetics and Pharmacogenomics
Bedside Pharmacogenomic Test Prevents Deafness in Newborns by Detecting Genetic Risk for Abnormal Response to Common Antibiotic
New rapid pharmacogenomic point-of-care genetic test for preventing deafness in babies begins clinical use.
Majority of Pharmacists Unprepared to Provide Pharmacogenetic Treatments, New Survey Shows
Raises questions about what education and training is necessary for community, hospital, and health system pharmacists and other clinicians supporting pharmacogenomics.
Newly Introduced Bipartisan Bill Would Increase Public Awareness of Benefits of Pharmacogenetic Treatments
With a focus on pharmacogenomics testing, proposed legislation would boost public demand for precision medicine treatments and build better electronic infrastructure to support precision medicine.
Blue Care Network of Michigan to Launch Pharmacogenomic Personalized Medicine Program
The adoption of a precision medicine program by such a large insurer is expected to significantly expand the availability of precision medicine options within the state.
Precision Medicine Testing Executives Face Federal Jail Time After Violating Anti-Kickback Laws for Pharmacogenetic Testing
Illegal financial underpinnings brought charges in a large conspiracy involving iIllicit payment schemes for certain kinds of precision medicine testing.
Denmark Research Finds that a Combination of Genes Causes Medication Side Effects and Deficiencies in Most Patients
New research from Aarhus University, recently published in Translational Psychiatry, analyzed the frequency of genetic variations that affect drug metabolism and drug targets in over 77,000 patients. What the study found.